Madrid, Spain

Francisco Javier Ramos Lima

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Francisco Javier Ramos Lima: Innovator in Kinase Inhibitors

Introduction

Francisco Javier Ramos Lima is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of two patents to his name, his work focuses on compounds that have the potential to treat various diseases, including cancer.

Latest Patents

One of his latest patents is titled "Tricyclic compounds for use as kinase inhibitors." This patent describes compounds of formula (I), which are useful in the treatment of diseases where inhibition of a protein or lipid kinase is desired. Specifically, these compounds target PIM family kinases, such as PIM-1, PIM-2, and PIM-3, and are particularly relevant in cancer treatment. Another significant patent is for "Inhibitors of PI3 kinase," which also involves compounds of formula (I). These compounds are designed to inhibit protein or lipid kinases, including PI3-K and mTOR, and are aimed at treating cancer and proliferative diseases.

Career Highlights

Francisco has worked with esteemed organizations such as the Fundación Centro Nacional de Investigaciones Oncológicas Carlos III. His research and innovations have contributed to advancements in cancer treatment and therapeutic strategies.

Collaborations

Throughout his career, Francisco has collaborated with notable colleagues, including Joaquin Pastor Fernández and Sonia Martinez Gonzalez. These partnerships have enhanced his research efforts and broadened the impact of his inventions.

Conclusion

Francisco Javier Ramos Lima is a distinguished inventor whose work in kinase inhibitors has the potential to revolutionize cancer treatment. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…